Medicare Change Heralds Easier Device Trial Reimbursements

Law360, New York (July 26, 2013, 8:01 PM EDT) -- Medicare’s decisions about whether to cover certain costs in clinical trials for medical devices could become much more consistent under a proposal to centralize review instead of using numerous contractors, though concerns linger about how reviewers will apply potentially subjective standards, experts say.

In a proposed rule issued earlier this month, the Centers for Medicare and Medicaid Services floated the centralization plan and outlined more than a dozen standards to which trials must adhere if taxpayers are going to foot part of the bill.

“Appropriate study...
To view the full article, register now.